{"formats":[{"name":"JSON","format":"json","url":"\/downloads\/2025\/code-json\/32.1-73.22.json"},{"name":"Plain Text","format":"text","url":"\/downloads\/2025\/code-text\/32.1-73.22.txt"},{"name":"XML","format":"xml","url":"\/downloads\/2025\/code-xml\/32.1-73.22.xml"},{"name":"HTML","format":"html","url":"\/downloads\/2025\/code-html\/32.1-73.22.html"}],"law_id":56263,"edition_id":1,"section_id":56263,"structure_id":14667,"section_number":"32.1-73.22","catch_line":"Information from hospitals, clinics, certain laboratories, and physicians supplied to Commissioner; statewide sickle cell disease registry","history":"2024, c. 437.","full_text":"A\n\nEach hospital, clinic, and independent pathology laboratory shall make available to the Commissioner or his agents information on patients having sickle cell disease. A physician shall report information on patients having sickle cell disease unless he has determined that a hospital, clinic, or in-state pathology laboratory has reported the information. Such information shall include the name, address, sex, race, diagnosis, trait status, newborn screening data, and any other pertinent identifying information regarding each such patient. Each hospital, clinic, independent pathology laboratory, or physician shall provide other available clinical information as defined by the Board.B\n\nFrom such information the Commissioner shall establish and maintain a statewide sickle cell disease registry. The purpose of the statewide sickle cell disease registry shall include:1\n\nDetermining means of improving the diagnosis and treatment of sickle cell disease patients.2\n\nDetermining the need for and means of providing better long-term, follow-up care to sickle cell disease patients.3\n\nConducting epidemiological analyses of the incidence, prevalence, survival, and risk factors associated with the occurrence of sickle cell disease in Virginia.4\n\nImproving rehabilitative programs for sickle cell disease patients.5\n\nAssisting in the training of hospital personnel.6\n\nDetermining other needs of sickle cell disease patients and health personnel.","order_by":null,"text":{"0":{"id":206057,"text":"Each hospital, clinic, and independent pathology laboratory shall make available to the Commissioner or his agents information on patients having sickle cell disease. A physician shall report information on patients having sickle cell disease unless he has determined that a hospital, clinic, or in-state pathology laboratory has reported the information. Such information shall include the name, address, sex, race, diagnosis, trait status, newborn screening data, and any other pertinent identifying information regarding each such patient. Each hospital, clinic, independent pathology laboratory, or physician shall provide other available clinical information as defined by the Board.","type":"section","prefixes":["A"],"prefix":"A","entire_prefix":"A","prefix_anchor":"A","level":1,"next_prefix":"B"},"1":{"id":206058,"text":"From such information the Commissioner shall establish and maintain a statewide sickle cell disease registry. The purpose of the statewide sickle cell disease registry shall include:","type":"section","prefixes":["B"],"prefix":"B","entire_prefix":"B","prefix_anchor":"B","level":1,"prior_prefix":"A","next_prefix":"B1"},"2":{"id":206059,"text":"Determining means of improving the diagnosis and treatment of sickle cell disease patients.","type":"section","prefixes":["B","1"],"prefix":"1","entire_prefix":"B1","prefix_anchor":"B1","level":2,"prior_prefix":"B","next_prefix":"B2"},"3":{"id":206060,"text":"Determining the need for and means of providing better long-term, follow-up care to sickle cell disease patients.","type":"section","prefixes":["B","2"],"prefix":"2","entire_prefix":"B2","prefix_anchor":"B2","level":2,"prior_prefix":"B1","next_prefix":"B3"},"4":{"id":206061,"text":"Conducting epidemiological analyses of the incidence, prevalence, survival, and risk factors associated with the occurrence of sickle cell disease in Virginia.","type":"section","prefixes":["B","3"],"prefix":"3","entire_prefix":"B3","prefix_anchor":"B3","level":2,"prior_prefix":"B2","next_prefix":"B4"},"5":{"id":206062,"text":"Improving rehabilitative programs for sickle cell disease patients.","type":"section","prefixes":["B","4"],"prefix":"4","entire_prefix":"B4","prefix_anchor":"B4","level":2,"prior_prefix":"B3","next_prefix":"B5"},"6":{"id":206063,"text":"Assisting in the training of hospital personnel.","type":"section","prefixes":["B","5"],"prefix":"5","entire_prefix":"B5","prefix_anchor":"B5","level":2,"prior_prefix":"B4","next_prefix":"B6"},"7":{"id":206064,"text":"Determining other needs of sickle cell disease patients and health personnel.","type":"section","prefixes":["B","6"],"prefix":"6","entire_prefix":"B6","prefix_anchor":"B6","level":2,"prior_prefix":"B5"}},"ancestry":[{"id":14667,"edition_id":1,"name":"Statewide Sickle Cell Disease Registry","identifier":"22","label":"article","depth":3,"order_by":1,"parent_id":13607,"metadata":{},"date_created":"2026-06-26 03:49:14","date_modified":"2026-06-26 03:49:14","permalink":{"id":201901,"object_type":"structure","relational_id":14667,"identifier":"22","token":"32.1\/2\/22","url":"\/32.1\/2\/22\/","edition_id":1,"permalink":0,"preferred":1}},{"id":13607,"edition_id":1,"name":"Disease Prevention and Control","identifier":"2","label":"chapter","depth":2,"order_by":1,"parent_id":12727,"metadata":{},"date_created":"2026-06-26 03:45:22","date_modified":"2026-06-26 03:45:22","permalink":{"id":201743,"object_type":"structure","relational_id":13607,"identifier":"2","token":"32.1\/2","url":"\/32.1\/2\/","edition_id":1,"permalink":0,"preferred":1}},{"id":12727,"edition_id":1,"name":"Health","identifier":"32.1","label":"title","depth":1,"order_by":1,"parent_id":null,"metadata":{},"date_created":"2026-06-26 03:43:50","date_modified":"2026-06-26 03:43:50","permalink":{"id":201099,"object_type":"structure","relational_id":12727,"identifier":"32.1","token":"32.1","url":"\/32.1\/","edition_id":1,"permalink":0,"preferred":1}}],"structure_contents":[{"id":56263,"structure_id":14667,"section_number":"32.1-73.22","catch_line":"Information from hospitals, clinics, certain laboratories, and physicians supplied to Commissioner; statewide sickle cell disease registry","url":"\/32.1-73.22\/","token":"32.1\/2\/22\/32.1-73.22","metadata":false},{"id":82517,"structure_id":14667,"section_number":"32.1-73.23","catch_line":"Collection of sickle cell disease case information by the Commissioner","url":"\/32.1-73.23\/","token":"32.1\/2\/22\/32.1-73.23","metadata":false},{"id":68156,"structure_id":14667,"section_number":"32.1-73.24","catch_line":"Confidential nature of information supplied; publication; reciprocal data-sharing agreements","url":"\/32.1-73.24\/","token":"32.1\/2\/22\/32.1-73.24","metadata":false},{"id":78812,"structure_id":14667,"section_number":"32.1-73.25","catch_line":"Penalties for unauthorized use of statewide sickle cell disease registry","url":"\/32.1-73.25\/","token":"32.1\/2\/22\/32.1-73.25","metadata":false},{"id":76725,"structure_id":14667,"section_number":"32.1-73.26","catch_line":"Notification of sickle cell disease patients of statewide sickle cell disease registry reporting","url":"\/32.1-73.26\/","token":"32.1\/2\/22\/32.1-73.26","metadata":false},{"id":83107,"structure_id":14667,"section_number":"32.1-73.27","catch_line":"Annual report; sickle cell disease registry","url":"\/32.1-73.27\/","token":"32.1\/2\/22\/32.1-73.27","metadata":false}],"next_section":{"id":82517,"structure_id":14667,"section_number":"32.1-73.23","catch_line":"Collection of sickle cell disease case information by the Commissioner","url":"\/32.1-73.23\/","token":"32.1\/2\/22\/32.1-73.23","metadata":false},"metadata":false,"official_url":"https:\/\/law.lis.virginia.gov\/vacode\/32.1-73.22\/","history_text":"

This law was first created in 2024. The record of its establishment is cataloged in chapter 437<\/a> of that year\u2019s edition of \u201cActs of Assembly,\u201d the annual state publication listing all changes made to the Code of Virginia in that year.<\/p>","references":[{"id":82517,"section_number":"32.1-73.23","catch_line":"Collection of sickle cell disease case information by the Commissioner","order_by":null,"url":"\/32.1-73.23\/"},{"id":68156,"section_number":"32.1-73.24","catch_line":"Confidential nature of information supplied; publication; reciprocal data-sharing agreements","order_by":null,"url":"\/32.1-73.24\/"},{"id":76725,"section_number":"32.1-73.26","catch_line":"Notification of sickle cell disease patients of statewide sickle cell disease registry reporting","order_by":null,"url":"\/32.1-73.26\/"}],"refers_to":false,"permalink":{"id":201903,"object_type":"law","relational_id":56263,"identifier":"32.1-73.22","token":"32.1\/2\/22\/32.1-73.22","url":"\/32.1-73.22\/","edition_id":1,"permalink":0,"preferred":1},"url":"\/32.1-73.22\/","token":"32.1\/2\/22\/32.1-73.22","dublin_core":{"Title":"Information from hospitals, clinics, certain laboratories, and physicians supplied to Commissioner; statewide sickle cell disease registry","Type":"Text","Format":"text\/html","Identifier":"\u00a7 32.1-73.22","Relation":"Code of Virginia"},"html":"\n\t\t\t\t\t\t

A.<\/span> Each hospital, clinic, and independent pathology laboratory shall make available to the Commissioner<\/span> or his agents information on patients having sickle cell disease. A physician shall report information on patients having sickle cell disease unless he has determined that a hospital, clinic, or in-state pathology laboratory has reported the information. Such information shall include the name, address, sex, race, diagnosis, trait status, newborn screening data, and any other pertinent identifying information regarding each such patient. Each hospital, clinic, independent pathology laboratory, or physician shall provide other available clinical information as defined by the Board<\/span>. <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

B.<\/span> From such information the Commissioner<\/span> shall establish and maintain a statewide sickle cell disease registry. The purpose of the statewide sickle cell disease registry shall include: <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

1.<\/span> Determining means of improving the diagnosis and treatment of sickle cell disease patients. <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

2.<\/span> Determining the need for and means of providing better long-term, follow-up care to sickle cell disease patients. <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

3.<\/span> Conducting epidemiological analyses of the incidence, prevalence, survival, and risk factors associated with the occurrence of sickle cell disease in Virginia. <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

4.<\/span> Improving rehabilitative programs for sickle cell disease patients. <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

5.<\/span> Assisting in the training of hospital personnel. <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

6.<\/span> Determining other needs of sickle cell disease patients and health personnel. <\/i><\/a><\/p><\/section>","plain_text":" CODE OF VIRGINIA\n\nINFORMATION FROM HOSPITALS, CLINICS, CERTAIN LABORATORIES, AND PHYSICIANS\nSUPPLIED TO COMMISSIONER; STATEWIDE SICKLE CELL DISEASE REGISTRY (\u00a7 32.1-73.22)\n\nA. Each hospital, clinic, and independent pathology laboratory shall make\navailable to the Commissioner or his agents information on patients having\nsickle cell disease. A physician shall report information on patients having\nsickle cell disease unless he has determined that a hospital, clinic, or\nin-state pathology laboratory has reported the information. Such information\nshall include the name, address, sex, race, diagnosis, trait status, newborn\nscreening data, and any other pertinent identifying information regarding each\nsuch patient. Each hospital, clinic, independent pathology laboratory, or\nphysician shall provide other available clinical information as defined by the\nBoard.\n\nB. From such information the Commissioner shall establish and maintain a\nstatewide sickle cell disease registry. The purpose of the statewide sickle cell\ndisease registry shall include:\n\n 1. Determining means of improving the diagnosis and treatment of sickle cell\n disease patients.\n\n 2. Determining the need for and means of providing better long-term, follow-up\n care to sickle cell disease patients.\n\n 3. Conducting epidemiological analyses of the incidence, prevalence, survival,\n and risk factors associated with the occurrence of sickle cell disease in\n Virginia.\n\n 4. Improving rehabilitative programs for sickle cell disease patients.\n\n 5. Assisting in the training of hospital personnel.\n\n 6. Determining other needs of sickle cell disease patients and health\n personnel.\n\nHISTORY: 2024, c. 437.","edition":{"id":1,"name":"2025","slug":"2025","date_created":"2026-06-21 22:39:22","date_modified":"2026-06-21 22:39:22","current":1,"order_by":1,"last_import":null}}